Corcept Therapeutics Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for CORT, updated each market day.
CORT AI Sentiment
AI predicts Corcept Therapeutics Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Corcept Therapeutics Inc.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Sector
Exchange
Market Cap
$4,494,302,345
Cap Tier
Employees
730
Headquarters
REDWOOD CITY, CA
Listed Since
April 14, 2004
Website
CORT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CORT Volatility
Corcept Therapeutics Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
